Lunai Bioworks News and Activities

Lunai Bioworks is a company listed under the stock ticker LNAI (US).

Acquisition, funding and merger involving Lunai Bioworks.

• Predictive Oncology and Lunai Bioworks have announced they will merge  (posted on January 7 2025)..

View the org chart displaying its 6 main executives

Most searched biographies at Lunai Bioworks

• David Weinstein, Director and Chief Executive Officer
• Mark Collins, Director
• James Mcnulty, Director

Create your alert
to follow the executive moves at Lunai Bioworks.

Lunai Bioworks has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Lunai Bioworks

• News
• News
• News – Renovaro Biosciences
• News
• PersonalAIze and Cube Forge Groundbreaking Partnership - Renovaro Group
• RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress - Renovaro Group
• Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform - Renovaro Group
• RenovaroCube Announces Strategic Offering of Up to 20% Ownership - Renovaro Group
• View more press releases Close

Social media about Lunai Bioworks

• Lunai Bioworks on Wikipedia, Google News & Yahoo Finance
• Lunai Bioworks on LinkedIn, X (Twitter) & YouTube